ondansetron has been researched along with Cross Infection in 1 studies
Ondansetron: A competitive serotonin type 3 receptor antagonist. It is effective in the treatment of nausea and vomiting caused by cytotoxic chemotherapy drugs, including cisplatin, and has reported anxiolytic and neuroleptic properties.
Cross Infection: Any infection which a patient contracts in a health-care institution.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Orsini, M | 1 |
| Otaíza, F | 1 |
| Vega, P | 1 |
| Hederra, LM | 1 |
| Pidal, P | 1 |
| Salas, V | 1 |
| Coria, P | 1 |
| Urízar, C | 1 |
| Sepúlveda, D | 1 |
| Palma, M | 1 |
| Fernández, J | 1 |
| Martínez, MC | 1 |
| Hormazábal, JC | 1 |
1 other study available for ondansetron and Cross Infection
| Article | Year |
|---|---|
[Outbreak of fungemias by Sarocladium kiliense in eight public hospitals per intrinsic contamination of ondansetron intravenous].
Topics: Adolescent; Child; Child, Preschool; Chile; Cross Infection; Disease Outbreaks; Drug Contamination; | 2018 |